Thanks to coronavirus-related wellness trends, the UK's vitamins and mineral supplementns market is set to be worth $664m by the end of the year, according to Mintel. But to make sure this increased demand is here to stay, consumer health companies need to leverage the power of digital to help consumers establish long-term supplementation habits into the future. 

Close monitoring of the effectiveness of coronavirus vaccines will be necessary after a new variant of SARS-CoV-2 was reported to be causing a rapid increase in transmission of the virus in the UK. The pharmaceutical industry says companies are not expecting travel restrictions imposed on the UK to have an impact on the supply of medicines.

In its latest letter to medicines and medical product companies, the UK's Department of Health and Social Care says the biggest potential cause of disruption to supplies could be failure to prepare for border controls implemented by the EU member states after the end of the Brexit transition period.